Your browser doesn't support javascript.
loading
Cardiovascular risks associated with dipeptidyl peptidase-4 inhibitors monotherapy compared with other antidiabetes drugs in the Japanese population: A nationwide cohort study.
Komamine, Maki; Kajiyama, Kazuhiro; Ishiguro, Chieko; Uyama, Yoshiaki.
Afiliação
  • Komamine M; Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Kajiyama K; Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Ishiguro C; Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Uyama Y; Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
Pharmacoepidemiol Drug Saf ; 28(9): 1166-1174, 2019 09.
Article em En | MEDLINE | ID: mdl-31338935
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Idioma: En Ano de publicação: 2019 Tipo de documento: Article